Reference 2017-698

REF:            2017-698

Subject:        Eczema patients

 

 

Request:

How many patients are currently being treated for moderate or severe atopic dermatitis (also known as eczema)?

Please split these patients by their current drug treatment; Acitretin, Alitretinoin,     Pimecrolimus,       Tacrolimus,   Dupixient (dupilumab),     Phototherapy including with ultraviolet (UVB) radiation or psoralen-ultraviolet A (PUVA), Potent Topical Corticosteroids (see list below)    Immunosuppressive therapies (see list below).

 

 

Potent Topical Corticosteroids [creams or ointments]

  • Amcinonide 0.05% (Cyclocort)
  • Betamethasone diproprionate 0.05% (Diprosone)
  • Betamethasone valerate
  • Clobetasol propionate
  • Desoximetasone 0.25% (Topicort)
  • Diflucortolone valerate
  • Fluocinonide 0.05% (Lidex)
  • Fluticasone proprionate 0.005% (Cutivate)
  • Halcinonide 0.05% (Halog)
  • Mometasone furoate 0.1% (Elocon ointment)
  • Triamcinalone acetonide 0.5% (Kenalog, Aristocort cream)
  • Betamethasone diproprionate 0.25% (Diprolene)
  • Clobetasol diproprionate 0.05% (Temovate)
  • Diflorasone diacetate 0.05% (Psorcon)
  • Halbetasol proprionate 0.05% (Ultravate)

 

Immunosuppressive therapies

  • Azathioprine
  • Ciclosporin
  • methotrexate

 

 

 

Response:

We do no record this information.